Oncology Hospital Director: Family has cancer don't hide.

When it comes to lung cancer, a lot of people talk about color change. In China, more than 610,000 people die of lung cancer every year, with about 730,000 new cases.Mao Weimin, director of the
's Zhejiang Cancer Hospital, said the incidence of lung cancer in Zhejiang Province has increased significantly in recent years. On the one hand, the incidence itself is steadily increasing, on the other hand, the introduction and popularization of health check-ups has led to the effective diagnosis of many patients at an early age.
Although the incidence of lung cancer in Zhejiang is higher than that of the whole country, the mortality rate is lower than that of the whole country. Mao Weimin analysis, this is related to The relatively developed economic level of Zhejiang Province, high level of medical care, the people's attention to health. "This also reflects the high level of cancer diagnosis and treatment in Zhejiang Province, tumor patients have been better diagnosed and treated."
tumor is a kind of "old age", "chronic disease", so, to face it with the right attitude, do not have to "talk about cancer color change", also should not completely hide the patient's condition.
many family members in order not to let patients know the condition, see a doctor dare not take to the oncology specialist to see, but to see some internal medicine, surgery and other departments, such a practice is not conducive to treatment, or even delay the disease. Mao Weimin said that from the data, the tumor mortality rate and cardiovascular disease is not comparable, but many people have high blood pressure, diabetes, still inappropriate; In fact, if early detection of early treatment, tumors can also be cured or controlled.
at present, the treatment of lung cancer is different from person to person. Usually, the first surgical treatment of early and middle-aged patients, that is, surgery, especially early patients, a single surgical treatment can be cured;
Mao Weimin introduced that in recent years, with the advent of targeted drugs, patients with advanced lung cancer see hope. "For example, patients with lung adenocarcinoma, the appearance of epidermal growth factor mutations, can be treated with targeted drugs."
, the median survival of advanced patients was only 6-8 months, and now with targeted drugs, the median survival of the elderly can reach nearly 30 months.
.